| $350M | ||
| $241M | ||
| $172M | ||
| $109M | ||
| $107M | ||
| $104M |
Buys | $0 | 0 | – |
Sells | $0 | 0 | – |
Champions Oncology, Inc. is dedicated to developing and commercializing cutting-edge technological products and services designed to personalize cancer treatment and streamline the development of oncology drugs across the United States. At the heart of its offerings is the Tumorgraft Technology Platform, an innovative approach that facilitates individualized cancer care by implanting human tumors into immune-deficient mice. Utilizing this proprietary platform, the company not only delivers personalized cancer solutions directly but also provides Translational Oncology Solutions, supporting pharmaceutical and biotechnology companies through their drug development lifecycle. Additionally, Champions Oncology offers Lumin Bioinformatics, a comprehensive software platform and data tool filled with insights from research services and clinical studies, accessible through annual subscriptions. The company distributes its offerings through various channels, including online platforms, word-of-mouth referrals, and a dedicated sales team, reaching both patients and healthcare professionals. Established in 1985, Champions Oncology, Inc. is based in Hackensack, New Jersey, and was formerly known as Champions Biotechnology, Inc. until its name change in April 2011.
Over the last 12 months, insiders at Champions Oncology, Inc. have bought $0 and sold $0 worth of Champions Oncology, Inc. stock.
On average, over the past 5 years, insiders at Champions Oncology, Inc. have bought $245,869 and sold $0 worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 1,000 shares for transaction amount of $6,500 was made by Mendelson Daniel Newman (director) on 2024‑01‑12.
| 2024-01-12 | Mendelson Daniel Newman | director | 1,000 0.0071% | $6.50 | $6,500 | -27.12% | ||
| 2024-01-11 | Mendelson Daniel Newman | director | 2,000 0.0147% | $6.27 | $12,540 | -21.18% | ||
| 2024-01-10 | Mendelson Daniel Newman | director | 2,944 0.022% | $6.31 | $18,577 | -20.33% | ||
| 2024-01-09 | Mendelson Daniel Newman | director | 3,000 0.0221% | $6.25 | $18,750 | -21.47% | ||
| 2024-01-08 | Mendelson Daniel Newman | director | 1,000 0.0074% | $6.15 | $6,150 | -20.20% | ||
| 2024-01-05 | Mendelson Daniel Newman | director | 2,000 0.0146% | $6.09 | $12,180 | -19.22% | ||
| 2024-01-04 | Mendelson Daniel Newman | director | 3,000 0.0221% | $6.12 | $18,360 | -19.67% | ||
| 2024-01-03 | Mendelson Daniel Newman | director | 500 0.0035% | $5.83 | $2,915 | -20.33% | ||
| 2023-12-21 | Mendelson Daniel Newman | director | 2,500 0.0184% | $4.92 | $12,300 | -0.20% | ||
| 2023-12-20 | Mendelson Daniel Newman | director | 2,100 0.015% | $4.82 | $10,122 | -1.41% | ||
| 2023-12-19 | Mendelson Daniel Newman | director | 5,000 0.0384% | $4.75 | $23,750 | +7.46% | ||
| 2023-10-11 | Mendelson Daniel Newman | director | 5,000 0.0385% | $6.40 | $32,000 | -18.72% | ||
| 2023-10-10 | Mendelson Daniel Newman | director | 1,100 0.008% | $6.41 | $7,051 | -21.44% | ||
| 2023-10-06 | Mendelson Daniel Newman | director | 1,530 0.0114% | $6.48 | $9,914 | -22.02% | ||
| 2023-10-05 | Mendelson Daniel Newman | director | 2,000 0.0156% | $6.47 | $12,940 | -18.87% | ||
| 2023-10-04 | Mendelson Daniel Newman | director | 5,000 0.0386% | $6.40 | $32,000 | -20.16% | ||
| 2023-10-03 | Mendelson Daniel Newman | director | 2,500 0.019% | $6.30 | $15,750 | -19.75% | ||
| 2023-09-29 | Mendelson Daniel Newman | director | 4,000 0.0294% | $6.16 | $24,640 | -18.68% | ||
| 2023-09-28 | Mendelson Daniel Newman | director | 5,000 0.0379% | $6.22 | $31,100 | -16.94% | ||
| 2023-09-27 | Mendelson Daniel Newman | director | 1,500 0.0115% | $5.95 | $8,925 | -12.63% |
| BROWN MICHAEL MAURICE | 10 percent owner | 22281040 160.0814% | $104.83M | 2 | 0 | |
| Battery Ventures IX, L.P. | 10 percent owner | 22281040 160.0814% | $104.83M | 2 | 0 | |
| Martell James | director | 2051828 14.7417% | $9.65M | 0 | 7 | |
| New Enterprise Associates 14, L.P. | 10 percent owner | 1713720 12.3125% | $8.06M | 0 | 1 | |
| ACKERMAN JOEL | director | 1021731 7.3408% | $4.81M | 10 | 1 | +66.05% |
| Morris Ronnie | CEO | 858878 6.1707% | $4.04M | 16 | 1 | +86.37% |
| Mendelson Daniel Newman | director | 198625 1.4271% | $934,530.63 | 30 | 2 | <0.0001% |
| BURKETT DOUGLAS D | President | 850 0.0061% | $3,999.25 | 3 | 0 | |
| Breitfeld Philip P. | director | 0 0% | $0 | 0 | 1 |
$5,831,763 | 118 | -33.78% | $61.75M | |
$9,405,928 | 107 | 12.61% | $69.86M | |
$17,525,882 | 60 | 5.22% | $62.7M | |
$103,288,323 | 51 | 4.78% | $61.16M | |
$66,137,559 | 49 | 6.29% | $70.03M | |
$77,146,704 | 43 | 13.28% | $77.85M | |
Champions Oncology, Inc. (CSBR) | $909,129 | 37 | 42.19% | $65.49M |
$115,646,156 | 35 | 16.45% | $59.08M | |
$1,602,584 | 20 | 15.26% | $68.66M | |
$3,606,967 | 19 | 9.60% | $67.1M | |
$11,267,080 | 15 | -22.36% | $64.65M | |
$13,919,584 | 9 | -30.43% | $64.74M | |
$106,599,960 | 6 | -7.63% | $67.73M | |
$110,013 | 5 | 6.58% | $73.42M | |
$401,951 | 4 | 57.41% | $59.76M | |
$762,555 | 4 | -34.52% | $70.85M | |
$67,369,250 | 3 | -22.09% | $62.14M | |
$110,261 | 3 | -45.30% | $58.49M | |
$4,030 | 1 | 9.14% | $74.15M |
| Increased Positions | 10 | +31.25% | 154,844 | +2.7% |
| Decreased Positions | 11 | -34.38% | 129,728 | -2.27% |
| New Positions | 3 | New | 98,744 | New |
| Sold Out Positions | 4 | Sold Out | 105,251 | Sold Out |
| Total Postitions | 31 | -3.13% | 6M | +0.44% |
| Battery Management Corp. | $16,128.00 | 17.3% | 2.42M | 0 | 0% | 2025-09-30 |
| Nea Management Company, Llc | $11,413.00 | 12.24% | 1.71M | 0 | 0% | 2025-09-30 |
| Vanguard Group Inc | $2,219.00 | 2.38% | 333,258 | +6,229 | +1.91% | 2025-09-30 |
| Tocqueville Asset Management L.P. | $2,129.00 | 2.28% | 319,674 | -80,208 | -20.06% | 2025-09-30 |
| Morgan Stanley | $1,263.00 | 1.35% | 189,600 | +59,100 | +45.29% | 2025-09-30 |
| Renaissance Technologies Llc | $1,114.00 | 1.2% | 167,261 | -13,778 | -7.61% | 2025-09-30 |
| Blackrock, Inc. | $812.00 | 0.87% | 121,910 | +1,081 | +0.9% | 2025-09-30 |
| Geode Capital Management, Llc | $496.00 | 0.53% | 74,409 | -776 | -1.03% | 2025-09-30 |
| Northern Trust Corp | $309.00 | 0.33% | 46,434 | -7,328 | -13.63% | 2025-09-30 |
| Acadian Asset Management Llc | $241.00 | 0.26% | 36,182 | 0 | 0% | 2025-09-30 |